Across CCLE and GDSC cell-line panels, response to Shikonin is significantly associated with the shRNA pathway dependency of multiple pathways, with LIVER cell lines showing a particularly strong set of associations.
The most reproducible Shikonin response-associated pathways across cancer lineages are Negative regulation of G2/M transition of mitotic cell cycle, Negative regulation of cell cycle G2/M phase transition, and Pericentric heterochromatin formation, each associated with drug response in up to 7 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Shikonin response versus Negative regulation of G2/M transition of mitotic cell cycle shRNA pathway dependency in LIVER (Pearson r = -0.73).